AKT1 and neoplasm: For example, LIC has been reported to exert anti-tumor effects by targeting PI3Kγ-AKT signaling pathway, reducing the expression of Arg1 and ROS, promoting apoptosis of MDSCs cells, and reducing the inhibition of CD8 + T cells [140].